Liver Pathology Vocabulary Flashcards

Diffuse Liver Disease

  • Definition: diffuse disease affects hepatocytes and impairs liver function; measured by elevated hepatic enzyme levels with cell necrosis.
  • Major diffuse diseases: Fatty infiltration, Hepatitis (acute and chronic), Cirrhosis (acute and chronic).

Fatty Infiltration (Fatty Liver)

  • Reversible accumulation of triglycerides in hepatocytes (steatosis).
  • Causes: obesity, excessive alcohol, hyperlipidemia, diabetes, corticosteroids, pregnancy, total parenteral nutrition, severe hepatitis, glycogen storage disease, cystic fibrosis, other drugs.
  • Focal fatty infiltration and focal fatty sparing: sparing often near gallbladder, porta hepatis, caudate lobe, liver margins.

Hepatitis

  • Inflammation/infectious disease of the liver; can be viral, bacterial, fungal, parasitic; toxins/drugs possible.
  • Acute vs chronic; may elevate ALT, AST, and bilirubin.
  • Viral types: HAV, HBV, HCV.
  • HAV: fecal-oral spread; endemic in developing countries; typically acute with recovery or death.
  • HBV: blood/fluids transmission; risk to healthcare workers; sexual transmission possible.
  • HCV: anti-HCV marker; blood/body fluids; often from needles or sexual contact.
  • US distribution: ~60% of acute hepatitis is B, ~20% A, ~20% other.
  • Acute hepatitis ultrasound: liver may be normal or slightly hyperechoic; Starry Night appearance; hepatosplenomegaly; gallbladder wall thickening; mild attenuation.
  • Chronic hepatitis ultrasound: coarse parenchyma; decreased brightness of portal triads; fibrosis with piecemeal necrosis; can have non-enlarged liver.

Cirrhosis

  • Definition: chronic degenerative liver disease with fibrous tissue covering lobes and parenchymal degeneration; lobules infiltrated with fat; disorganized architecture due to necrosis, regeneration, and diffuse fibrosis.
  • Causes: Hepatitis C (major), alcohol, NAFLD/NASH, HBV, hemochromatosis, Wilson disease, others.
  • Nodularity: micronodular (e.g., from alcohol) vs macronodular (viral/infection).
  • Clinical progression: ascites, varices, portal hypertension; potential progression to liver failure.
  • Ultrasound progression:
    • Early: hepatomegaly, increased echogenicity, coarse texture; vascular changes.
    • Mid: nodular borders, lobe atrophy, ascites.
    • Late: small shrunken liver, ascites, portal hypertension; risk of hepatocellular carcinoma.
  • Additional signs: thickened gallbladder wall; altered hepatic vasculature.

Glycogen Storage Disease

  • Six categories; most common is type I (von Gierke) with excess glycogen deposition in liver and kidneys.
  • Inheritance: autosomal dominant (as described in the source).
  • Ultrasound: hepatomegaly, increased echogenicity; round, homogeneous adenomas (seen in caudate/right lobe).

Hemochromatosis

  • Rare iron metabolism disorder with systemic iron deposition; can lead to cirrhosis and portal hypertension.
  • Ultrasound: hepatomegaly, cirrhotic changes, uniformly increased echogenicity of the liver parenchyma.

Focal Hepatic Disease

  • Simple hepatic cysts: well-demarcated, thin-walled, anechoic lesions with posterior acoustic enhancement; usually asymptomatic.
  • Polycystic liver disease: autosomal dominant; associated with polycystic kidney disease; multiple small cysts throughout liver; may enlarge and cause biliary obstruction at porta hepatis.

Focal Inflammatory Disease

  • Hepatic abscesses common complications of biliary disease, surgery, or trauma.
  • Types: Pyogenic (80%), Amebic, Echinococcal (hydatid), Fungal (Candida), Pneumocystis, Chronic Granulomatous Disease.
  • Pyogenic abscess: routes via biliary tract, portal vein, hepatic artery; fever, leukocytosis; biliary infections common.
  • Amebic abscess: Entamoeba histolytica; via portal system; travel/immigrant exposure; GI symptoms common.
  • Amebic abscess gross: necrotic material (not pus).
  • Echinococcal cyst: hydatid disease; water-lily sign; daughter cysts.
  • Candida (fungal): wheel-within-a-wheel or bull’s-eye appearance; hypoechoic focus.
  • Pneumocystis: diffuse tiny echogenic foci or extensive calcifications.
  • Chronic Granulomatous Disease: phagocyte defect; poorly marginated hypoechoic mass; calcifications possible; aspiration needed for diagnosis.

Benign Hepatic Tumors

  • Cavernous Hemangioma: most common benign liver tumor; female predominance; usually asymptomatic; irregular echogenicity due to vascular spaces.
  • Liver Cell Adenoma: more common in women; linked to oral contraceptives; rupture risk with bleeding; increased in glycogen storage disease; resection advised due to malignant transformation risk.
  • Lipoma: benign fat-containing lesion; ultrasound artifact possible.

Focal Nodular Hyperplasia

  • Second most common benign liver mass; occurs in women <40.
  • Often subcapsular; central fibrous scar; composed of normal hepatocytes, Kupffer cells, bile ducts, and fibrous tissue.
  • May be multiple nodules separated by fibrous bands; potential bleeding risk.

Hepatocellular Carcinoma (HCC)

  • Most common primary malignant liver tumor; more often a metastasis than primary overall.
  • Major risk factors: cirrhosis (80%), chronic HBV infection, aflatoxins; more common in men.
  • Patterns: solitary massive tumor, multiple nodules, or diffuse infiltrative masses.
  • Invasion: hepatic veins (potential Budd-Chiari), portal venous system; may destroy vessel walls with thrombosis.

Metastatic Disease

  • Most common form of liver neoplasm overall; primary sites include colon, breast, and lung.
  • Prognosis varies; ultrasound shows multiple well-defined iso-, hyper-, or hypoechoic nodules; necrosis common in centers.

Pediatric and Other Malignancies

  • Hepatoblastoma: most common malignant liver tumor in infants/children <2; enlarged asymptomatic mass; associated with Beckwith-Wiedemann syndrome; increased AFP; may metastasize to lungs; portal vein invasion.
  • Infantile Hepatic Hemangiomas: benign, rapid neonatal growth; high vascularity; may cause congestive heart failure; often spontaneously regress by 12–18 months.
  • Lymphoma: hepatomegaly with normal or diffusely altered parenchyma; focal hypoechoic masses possible; systemic symptoms common.

Elastography

  • Measures tissue stiffness; malignancies are stiffer than benign tissue.
  • Useful to assess fibrosis and cirrhosis; helps identify patients with little or no fibrosis who are harder to detect on ultrasound.

Ultrasound-Guided Liver Biopsy

  • Performed with ultrasound guidance to obtain tissue for histology (referenced in the material).

Hepatic Trauma

  • Liver is the third most commonly injured abdominal organ.
  • Lacerations occur in about 3% of trauma patients and often accompany other injuries.
  • Management depends on laceration size, amount of hemoperitoneum, and clinical status; right lobe injured more often.